Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease
Identifieur interne : 000815 ( Main/Curation ); précédent : 000814; suivant : 000816Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease
Auteurs : Aristide Merola [Italie] ; Maurizio Zibetti [Italie] ; Serena Angrisano [Italie] ; Laura Rizzi [Italie] ; Michele Lanotte [Italie] ; Leonardo Lopiano [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-03.
English descriptors
- KwdEn :
Abstract
Background:: Subthalamic nucleus deep brain stimulation (STN‐DBS) and levodopa/carbidopa enteral (Duodopa) infusion are two effective therapeutic options for the treatment of advanced Parkinson's disease (PD). Methods:: Retrospectively, this study compared the two procedures, evaluating 40 PD patients who underwent either STN‐DBS or a percutaneous gastrostomy (PEG) for Duodopa infusion. Duodopa group comprised 20 patients, with a mean follow‐up of ∼15 months, treated by Duodopa infusion rather than STN‐DBS because of the presence of neurosurgical contraindications, age > 70 years‐old, moderate cognitive impairment or patient's unwillingness to undergo neurosurgery. The STN‐DBS group comprised 20 consecutive patients similar to the patients of the Duodopa group for age at the disease onset, age at the procedure, follow‐up, and duration of motor complications. The only difference concerned neuropsychological functions, which were more impaired in the group of Duodopa patients. Clinical and neuropsychological data were compared at baseline and at follow‐up for the two procedures. Results:: Both procedures showed a significant improvement in UPDRS‐II, UPDRS‐III, and UPDRS‐IV and a considerable reduction in the percentage of waking day spent in “off,” whereas only the STN‐DBS group showed a significant improvement in dyskinesias duration and disability. STN‐DBS was associated to a significant drop in the phonemic verbal fluency score, whereas Duodopa patients showed a milder worsening in this task. The procedure‐related complications occurred more frequently with Duodopa. Conclusion:: STN‐DBS and Duodopa showed a significant efficacy on motor symptoms, activities of daily living, and motor complications. The group of Duodopa‐treated patients developed more procedure‐related complications. © 2011 Movement Disorder Society
Url:
DOI: 10.1002/mds.23524
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000937
Links to Exploration step
ISTEX:422E8EB64C0EBEFEF8F11E8B5368498D8E74BAD0Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease</title>
<author><name sortKey="Merola, Aristide" sort="Merola, Aristide" uniqKey="Merola A" first="Aristide" last="Merola">Aristide Merola</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zibetti, Maurizio" sort="Zibetti, Maurizio" uniqKey="Zibetti M" first="Maurizio" last="Zibetti">Maurizio Zibetti</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Angrisano, Serena" sort="Angrisano, Serena" uniqKey="Angrisano S" first="Serena" last="Angrisano">Serena Angrisano</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rizzi, Laura" sort="Rizzi, Laura" uniqKey="Rizzi L" first="Laura" last="Rizzi">Laura Rizzi</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lanotte, Michele" sort="Lanotte, Michele" uniqKey="Lanotte M" first="Michele" last="Lanotte">Michele Lanotte</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lopiano, Leonardo" sort="Lopiano, Leonardo" uniqKey="Lopiano L" first="Leonardo" last="Lopiano">Leonardo Lopiano</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:422E8EB64C0EBEFEF8F11E8B5368498D8E74BAD0</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/mds.23524</idno>
<idno type="url">https://api.istex.fr/document/422E8EB64C0EBEFEF8F11E8B5368498D8E74BAD0/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000937</idno>
<idno type="wicri:Area/Main/Curation">000815</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease</title>
<author><name sortKey="Merola, Aristide" sort="Merola, Aristide" uniqKey="Merola A" first="Aristide" last="Merola">Aristide Merola</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zibetti, Maurizio" sort="Zibetti, Maurizio" uniqKey="Zibetti M" first="Maurizio" last="Zibetti">Maurizio Zibetti</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Angrisano, Serena" sort="Angrisano, Serena" uniqKey="Angrisano S" first="Serena" last="Angrisano">Serena Angrisano</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rizzi, Laura" sort="Rizzi, Laura" uniqKey="Rizzi L" first="Laura" last="Rizzi">Laura Rizzi</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lanotte, Michele" sort="Lanotte, Michele" uniqKey="Lanotte M" first="Michele" last="Lanotte">Michele Lanotte</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lopiano, Leonardo" sort="Lopiano, Leonardo" uniqKey="Lopiano L" first="Leonardo" last="Lopiano">Leonardo Lopiano</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neuroscience, University of Torino, Torino, Italy</mods:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neuroscience, University of Torino, Torino</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-03">2011-03</date>
<biblScope unit="volume">26</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="664">664</biblScope>
<biblScope unit="page" to="670">670</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">422E8EB64C0EBEFEF8F11E8B5368498D8E74BAD0</idno>
<idno type="DOI">10.1002/mds.23524</idno>
<idno type="ArticleID">MDS23524</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Levodopa/carbidopa enteral infusion</term>
<term>Parkinson's disease</term>
<term>subthalamic nucleus deep brain stimulation</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background:: Subthalamic nucleus deep brain stimulation (STN‐DBS) and levodopa/carbidopa enteral (Duodopa) infusion are two effective therapeutic options for the treatment of advanced Parkinson's disease (PD). Methods:: Retrospectively, this study compared the two procedures, evaluating 40 PD patients who underwent either STN‐DBS or a percutaneous gastrostomy (PEG) for Duodopa infusion. Duodopa group comprised 20 patients, with a mean follow‐up of ∼15 months, treated by Duodopa infusion rather than STN‐DBS because of the presence of neurosurgical contraindications, age > 70 years‐old, moderate cognitive impairment or patient's unwillingness to undergo neurosurgery. The STN‐DBS group comprised 20 consecutive patients similar to the patients of the Duodopa group for age at the disease onset, age at the procedure, follow‐up, and duration of motor complications. The only difference concerned neuropsychological functions, which were more impaired in the group of Duodopa patients. Clinical and neuropsychological data were compared at baseline and at follow‐up for the two procedures. Results:: Both procedures showed a significant improvement in UPDRS‐II, UPDRS‐III, and UPDRS‐IV and a considerable reduction in the percentage of waking day spent in “off,” whereas only the STN‐DBS group showed a significant improvement in dyskinesias duration and disability. STN‐DBS was associated to a significant drop in the phonemic verbal fluency score, whereas Duodopa patients showed a milder worsening in this task. The procedure‐related complications occurred more frequently with Duodopa. Conclusion:: STN‐DBS and Duodopa showed a significant efficacy on motor symptoms, activities of daily living, and motor complications. The group of Duodopa‐treated patients developed more procedure‐related complications. © 2011 Movement Disorder Society</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000815 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000815 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonV1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:422E8EB64C0EBEFEF8F11E8B5368498D8E74BAD0 |texte= Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |